Phan Thanh T N, Thiono Devina J, Hvasta Matthew G, Shah Ruby P, Ajo Gisselle Prida, Huang Wei-Chiao, Lovell Jonathan F, Tian Shaomin, de Silva Aravinda M, Kuhlman Brian
Department of Biochemistry and Biophysics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
NPJ Vaccines. 2025 Jun 9;10(1):119. doi: 10.1038/s41541-025-01179-w.
The four serotypes of dengue virus (DENV1-4) are a major health concern putting 50% of the global population at risk of infection. Crucially, DENV vaccines must be tetravalent to provide protection against all four serotypes because immunity to only one serotype can enhance infections caused by heterologous serotypes. Uneven replication of live-attenuated viruses in tetravalent vaccines can lead to disease enhancement instead of protection. Subunit vaccines are a promising alternative as the vaccine components are not dependent on viral replication and antigen doses can be controlled to achieve a balanced response. Here, we show that a tetravalent subunit vaccine of dengue envelope (E) proteins computationally stabilized to form native-like dimers elicits type-specific neutralizing antibodies in mice against all four serotypes. The immune response was enhanced by displaying the E dimers on liposomes embedded with adjuvant, and no interference was detected between the four components.
登革病毒的四种血清型(DENV1 - 4)是一个重大的健康问题,使全球50%的人口面临感染风险。至关重要的是,登革病毒疫苗必须是四价的,以提供针对所有四种血清型的保护,因为仅对一种血清型产生免疫可能会增强由异源血清型引起的感染。四价疫苗中减毒活病毒的不均匀复制可能导致疾病增强而非保护作用。亚单位疫苗是一种有前景的替代方案,因为疫苗成分不依赖病毒复制,并且可以控制抗原剂量以实现平衡反应。在这里,我们表明,一种通过计算稳定形成天然样二聚体的登革病毒包膜(E)蛋白四价亚单位疫苗,在小鼠中引发了针对所有四种血清型的型特异性中和抗体。通过将E二聚体展示在包埋有佐剂的脂质体上,免疫反应得到增强,并且在四种成分之间未检测到干扰。